Is selenium supplementation indicated for autoimmune thyroid disease such as Hashimoto thyroiditis?

Selenium Supplementation for Autoimmune Thyroid Disease

Selenium supplementation is NOT routinely recommended for Hashimoto's thyroiditis or other autoimmune thyroid diseases, as there is insufficient outcome data to support its use for preventing or treating hypothyroidism in any population 1.

Evidence-Based Reasoning

The AACE/ATA clinical practice guidelines (2012) provide the definitive framework here, explicitly stating that despite selenium's theoretical potential for beneficial effects on thyroid autoimmunity, routine selenium use to prevent or treat hypothyroidism is not supported (Grade D, BEL 4) 1.

What the Evidence Actually Shows

Biochemical changes without clinical benefit:

• While selenium supplementation (typically 200 µg/day) may reduce anti-TPO antibody titers and potentially improve subjective well-being or mood, these changes do not translate into meaningful clinical outcomes 1
• No significant improvements occur in:
  • Thyroid gland ultrasonographic morphology
  • Levothyroxine dosing requirements
  • Thyroid function parameters (TSH, T4, T3)

Concerning safety signals from recent research:

• A 2024 meta-analysis of RCTs found selenium decreased TSH and TPOAb but with only moderate certainty of evidence 2

• Most alarmingly, a large 2026 retrospective cohort study (n=4,694) found selenium supplementation was associated with:

  • Persistently higher TSH, free T4, and TPOAb levels
  • Increased incidence of autoimmune disorders (RR 1.33), particularly Sjögren's syndrome and psoriasis
  • Increased all-cause mortality (RR 1.38,95% CI 1.09-2.03) 3

• Another 2026 study showed selenium supplementation increased anti-TPO and anti-Tg antibodies rather than decreasing them 4

Critical Nuances and Pitfalls

Geographic variability matters:

• The European trial showing benefit was conducted in a selenium-deficient population 1
• Results may not generalize to populations with adequate dietary selenium intake
• Most studies lack baseline selenium measurements, making it impossible to identify who might benefit 3

Potential harms:

• Selenium supplementation has been associated with increased diabetes risk 1
• The ESPEN guidelines (2022) note selenium overexposure is positively associated with type 2 diabetes and high-grade prostate cancer 5
• Toxicity can occur, though upper limits are not clearly defined 5

Clinical Algorithm

Do NOT routinely supplement selenium in Hashimoto's thyroiditis patients

Consider selenium ONLY if:

1. Documented selenium deficiency (plasma selenium <0.4 mmol/L or <32 µg/L) 5
2. Patient resides in known selenium-deficient geographic region
3. Patient has specific clinical scenarios requiring selenium (e.g., prolonged parenteral nutrition, burns, major trauma) 5

If supplementing for documented deficiency:

• Dose: 100 µg/day (enteral route preferred given good absorption) 5
• Duration: Monitor response; typically 2 weeks to restore levels 5
• Monitor: Recheck selenium levels and thyroid function
• Stop if no clinical benefit or if antibodies worsen

Common Pitfalls to Avoid

1. Do not supplement based solely on elevated TPOAb - antibody reduction does not improve clinical outcomes
2. Do not assume "natural" means safe - selenium toxicity and adverse outcomes are real concerns
3. Do not continue indefinitely - the longest supportive trial was only 6 months; long-term safety is questionable
4. Do not use in place of appropriate levothyroxine therapy - selenium is not a thyroid hormone replacement

The evidence has evolved significantly, with the most recent large-scale studies (2026) showing potential harm rather than benefit, directly contradicting earlier smaller trials that showed antibody reduction. When weighing morbidity, mortality, and quality of life—the priority outcomes—the current evidence does not support routine selenium supplementation and suggests potential harm.